SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-20-000339
Filing Date
2020-05-15
Accepted
2020-05-15 10:52:57
Documents
33
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q QUARTERLY REPORT f10q033120_10q.htm 10-Q 180719
2 EXHIBITS 31.1 AND 31.2 SECTION 302 CERTIFICATIONS f10q033120_ex31z1.htm EX-31.1 8388
3 EXHIBITS 32.1 AND 32.2 SECTION 906 CERTIFICATIONS f10q033120_ex32z1.htm EX-32.1 3528
  Complete submission text file 0001078782-20-000339.txt   1060248

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT marz-20200331_cal.xml EX-101.CAL 14945
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT marz-20200331_def.xml EX-101.DEF 38328
6 XBRL INSTANCE DOCUMENT marz-20200331.xml EX-101.INS 117623
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT marz-20200331_lab.xml EX-101.LAB 101607
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT marz-20200331_pre.xml EX-101.PRE 82533
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT marz-20200331.xsd EX-101.SCH 13632
Mailing Address 109 AMBERSWEET WAY, #401 DAVENPORT FL 33897
Business Address 109 AMBERSWEET WAY, #401 DAVENPORT FL 33897 732-723-7395
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 20881934
SIC: 2834 Pharmaceutical Preparations